Physiological and pharmacological determinants of sensitivity and resistance to 5-fluorouracil in lower animals and man. - Suppr | 超能文献

Physiological and pharmacological determinants of sensitivity and resistance to 5-fluorouracil in lower animals and man.

作者信息

Ardalan B, Cooney D, Macdonald J S

出版信息

Adv Pharmacol Chemother. 1980;17:289-321. doi: 10.1016/s1054-3589(08)60013-7.

DOI:10.1016/s1054-3589(08)60013-7

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Physiological and pharmacological determinants of sensitivity and resistance to 5-fluorouracil in lower animals and man.

Adv Pharmacol Chemother. 1980;17:289-321. doi: 10.1016/s1054-3589(08)60013-7.

2

Antimetabolites.

Curr Opin Oncol. 1992 Dec;4(6):1089-98. doi: 10.1097/00001622-199212000-00014.

3

Studies on mechanisms of 5-fluorouracil resistance in murine and human tumors.关于小鼠和人类肿瘤中5-氟尿嘧啶耐药机制的研究。

Bull Cancer. 1979;66(1):55-9.

4

Fluorouracil.氟尿嘧啶

Clin J Oncol Nurs. 1999 Oct;3(4):191-2.

5

[Effect of ascorbic acid on incorporation of 5-fluorouracil-6-3H into acid-soluble fraction and into RNA of sensitive and resistant to 5-fluorouracil cells of Ehrlich ascites carcinoma].[抗坏血酸对5-氟尿嘧啶-6-³H掺入艾氏腹水癌5-氟尿嘧啶敏感及耐药细胞酸溶性部分和RNA的影响]

Biull Eksp Biol Med. 1982 Feb;93(2):56-7.

6

Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture.培养的小鼠和人类细胞对5-氟尿嘧啶敏感性自然变异的基础。

Cancer Res. 1979 Feb;39(2 Pt 1):383-90.

7

Antimetabolites.抗代谢物

Cancer Chemother Biol Response Modif. 1992;13:1-30.

8

[Biochemical criteria of 5-fluorouracil sensitivity and resistance of stomach tumors].

Biull Eksp Biol Med. 1984 Nov;98(11):555-6.

9

The clinical pharmacology of antineoplastic agents (first of two parts).

N Engl J Med. 1975 May 22;292(21):1107-13. doi: 10.1056/NEJM197505222922107.

10

Can dihydropyrimidine dehydrogenase impact 5-fluorouracil-based treatment?二氢嘧啶脱氢酶会影响基于5-氟尿嘧啶的治疗吗？

Eur J Cancer. 2000 Jan;36(1):37-42. doi: 10.1016/s0959-8049(99)00211-7.

引用本文的文献

1

A phase II trial of FUdR in patients with advanced pancreatic cancer.氟尿苷用于晚期胰腺癌患者的II期试验。

J Cancer Res Clin Oncol. 2004 Oct;130(10):561-6. doi: 10.1007/s00432-004-0584-5. Epub 2004 Jul 29.

2

Tomudex (ZD1694): from concept to care, a programme in rational drug discovery.拓姆替克（ZD1694）：从概念到医疗，合理药物研发项目

Invest New Drugs. 1996;14(3):305-16. doi: 10.1007/BF00194534.

3

Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemia.（αS，5S）-2-氨基-3-氯-4,5-二氢-5-异恶唑乙酸与5-氟尿嘧啶在P388白血病中协同作用的生化机制。

Cancer Chemother Pharmacol. 1985;15(1):44-8. doi: 10.1007/BF00257293.